All In MedTech

Device Trial Radar · NCT01249144

Visual and Refractive Outcomes After Implantation of Aspheric IOLs With Different Dioptric Increments and Manufacturing

A Randomized Fellow-eye Controlled Clinical Trial to Compare the Visual and Refractive Outcomes Between Two Aspheric IOLs With Different Dioptric Increments and Manufacturing Tolerances in Patients Undergoing Bilateral Cataract Surgery

Last checked: Nov 19, 2026Latest source record: Oct 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

75

Actual

Start

Oct 2010

Primary completion

Jan 2012

Study completion Jan 2012

Sponsor

Lead sponsor
Lenstec IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Nov 29, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study compares two intraocular lenses, the Softec HD and the Tecnis Z9002, used to replace the natural crystalline lens after cataract extraction. The variables compared include 1) the accuracy of targeted versus achieved refractive outcomes and 2) visual acuity outcomes three months after implantation.

Conditions

  • Cataract

Interventions

  • Intraocular Lens (IOL)Device

    Device for implantation in the capsular bag of the eye for visual correction of aphakia following cataract surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target versus Achieved RefractionTime frame: 3 Months Postoperative

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St. Luke's Cataract & Laser Institute

    Tarpon Springs, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.